Patent Assignment
Reel/Frame 033069/0339
Assignment of Assignor's Interest
Recorded: 2014-06-10
Pages: 6
Assignor
HUANG, HAICHUN
Executed: 2012-04-12
Assignee
MEDAREX, INC.
ROUTE 206 & PROVINCE LINE ROAD, PRINCETON, NEW JERSEY, 08543
Covered Properties
(5)
Monoclonal Antibodies to Programmed Death 1 (Pd-1)
Methods for Treating Cancer Using Anti-Pd-1 Antibodies in Combination with Anti-Ctla-4 Antibodies
Monoclonal Antibodies to Programmed Death 1 (Pd-1)
Monoclonal Antibodies to Programmed Death 1 (Pd-1)
Methods for Treating Cancer Using Anti-Pd-1 Antibodies
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Merger
Jun 13, 2013
From: MEDAREX, INC.
To: MEDAREX, L.L.C.
Reel/Frame 030603/0924 →
Assignment of Assignor's Interest
Jun 10, 2014
From: KORMAN, ALAN J.; SRINIVASAN, MOHAN; WANG, CHANGYU; SELBY, MARK J.
To: MEDAREX, INC.
Reel/Frame 033069/0061 →
Assignment of Undivided 50% of Assignor's Interest
Jun 10, 2014
From: MEDAREX, INC.
To: ONO PHARMACEUTICAL CO., LTD.
Reel/Frame 033124/0053 →
Merger
Jun 11, 2014
From: MEDAREX, INC.
To: MEDAREX, L.L.C.
Reel/Frame 033080/0678 →
Merger
Nov 7, 2014
From: MEDAREX, L.L.C.
To: E. R. SQUIBB & SONS, L.L.C.
Reel/Frame 034126/0342 →
Corrective Assignment to Correct the Incorrect Spelling of Inventor "Bing Chen" to "Bingliang Chen" Previously Recorded on Reel 033069 Frame 0061. Assignor(S) Hereby Confirms the Correct Spelling of Inventor as "Bingliang Chen".
Feb 4, 2015
From: KORMAN, ALAN J.; SRINIVASAN, MOHAN; WANG, CHANGYU; SELBY, MARK J.
To: MEDAREX, INC.
Reel/Frame 034905/0592 →